ABSTRACT
Introduction ....................................................................................................................................441 Nucleotide Reverse Transcriptase Inhibitors (NRTIs) ..................................................................442 Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) .........................................................446 Protease Inhibitors (PIs).................................................................................................................446 Fusion Inhibitors ............................................................................................................................448 References ......................................................................................................................................450
